Christopher Upton

Array ( [id] => 11542872 [patent_doc_number] => 20170096696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-06 [patent_title] => 'Hybrid Suppressor tRNA for Vertebrate Cells' [patent_app_type] => utility [patent_app_number] => 14/820318 [patent_app_country] => US [patent_app_date] => 2015-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 37965 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14820318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11852057 [patent_doc_number] => 20170226550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'INHIBITORY RNA FOR ENHANCED PROTEIN PRODUCTION IN RECOMBINANT MAMMALIAN CELLS' [patent_app_type] => utility [patent_app_number] => 15/501503 [patent_app_country] => US [patent_app_date] => 2015-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15565 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15501503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10686099 [patent_doc_number] => 20160032244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'Method of inducing cellular differentiation using the Notch3 receptor intracellular domain' [patent_app_type] => utility [patent_app_number] => 14/817188 [patent_app_country] => US [patent_app_date] => 2015-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12832 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14817188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11670418 [patent_doc_number] => 20170159138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'METHODS AND SYSTEMS FOR DETERMINING ONCOGENIC INDEX OF PATIENT SPECIFIC MUTATIONS' [patent_app_type] => utility [patent_app_number] => 15/327505 [patent_app_country] => US [patent_app_date] => 2015-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 31521 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15327505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11670417 [patent_doc_number] => 20170159137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'METHODS FOR DETERMINING DRUG RESPONSE OF PATIENT SPECIFIC MUTATIONS' [patent_app_type] => utility [patent_app_number] => 15/327499 [patent_app_country] => US [patent_app_date] => 2015-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 26074 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15327499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10663969 [patent_doc_number] => 20160010113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-14 [patent_title] => 'COMPOSITIONS AND METHODS FOR ENGINEERING CELLS' [patent_app_type] => utility [patent_app_number] => 14/801757 [patent_app_country] => US [patent_app_date] => 2015-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 26633 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14801757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11836319 [patent_doc_number] => 20170218039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-03 [patent_title] => 'N-TERMINALLY TRUNCATED INTERLEUKIN-38' [patent_app_type] => utility [patent_app_number] => 15/328690 [patent_app_country] => US [patent_app_date] => 2015-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10305 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15328690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11867571 [patent_doc_number] => 20170234856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-17 [patent_title] => 'DETECTION METHOD USING RECOMBINANT LIVING CELLS FOR DETECTING XENOBIOTIC SUBSTANCES AND ARRANGEMENT AND TEST KIT FOR PERFORMING THE DETECTION METHOD' [patent_app_type] => utility [patent_app_number] => 15/502787 [patent_app_country] => US [patent_app_date] => 2015-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6927 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11634039 [patent_doc_number] => 09655993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-23 [patent_title] => 'Tissue-engineered silk organs' [patent_app_type] => utility [patent_app_number] => 14/793464 [patent_app_country] => US [patent_app_date] => 2015-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 8913 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14793464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11365307 [patent_doc_number] => 20170003277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-05 [patent_title] => 'BIOLOGICAL CHARACTERIZATION OF A GLATIRAMER ACETATE RELATED DRUG PRODUCT USING MAMMALIAN AND HUMAN CELLS' [patent_app_type] => utility [patent_app_number] => 14/789833 [patent_app_country] => US [patent_app_date] => 2015-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 125091 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14789833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12885991 [patent_doc_number] => 20180187172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-05 [patent_title] => REGULATED GENE EXPRESSION FROM VIRAL VECTORS [patent_app_type] => utility [patent_app_number] => 15/323237 [patent_app_country] => US [patent_app_date] => 2015-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14829 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15323237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11627301 [patent_doc_number] => 20170137491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-18 [patent_title] => 'Novel Method' [patent_app_type] => utility [patent_app_number] => 15/317777 [patent_app_country] => US [patent_app_date] => 2015-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8623 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11589970 [patent_doc_number] => 20170114381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-27 [patent_title] => 'METHODS FOR HARVESTING MAMMALIAN CELL CULTURES' [patent_app_type] => utility [patent_app_number] => 15/316147 [patent_app_country] => US [patent_app_date] => 2015-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23547 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11727116 [patent_doc_number] => 20170188559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-06 [patent_title] => 'GENE EXPRESSION SYSTEM' [patent_app_type] => utility [patent_app_number] => 15/313922 [patent_app_country] => US [patent_app_date] => 2015-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19755 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10737584 [patent_doc_number] => 20160083735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-24 [patent_title] => 'PROMOTER' [patent_app_type] => utility [patent_app_number] => 14/721061 [patent_app_country] => US [patent_app_date] => 2015-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9484 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14721061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10367316 [patent_doc_number] => 20150252321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'Method of Enhancing Cell Growth Using Alkyl-Amine-N-Oxide (AANOX)' [patent_app_type] => utility [patent_app_number] => 14/717346 [patent_app_country] => US [patent_app_date] => 2015-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7518 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14717346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10355204 [patent_doc_number] => 20150240209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'METHODS FOR THE PREPARATION OF FIBROBLASTS' [patent_app_type] => utility [patent_app_number] => 14/708622 [patent_app_country] => US [patent_app_date] => 2015-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9919 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14708622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13065867 [patent_doc_number] => 10053708 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-21 [patent_title] => TCR(alpha)-LCR-derived gene regulatory cassettes [patent_app_type] => utility [patent_app_number] => 15/309995 [patent_app_country] => US [patent_app_date] => 2015-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 30 [patent_no_of_words] => 4394 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15309995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12044777 [patent_doc_number] => 09822369 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-21 [patent_title] => 'SDF-1 binding nucleic acids' [patent_app_type] => utility [patent_app_number] => 14/705809 [patent_app_country] => US [patent_app_date] => 2015-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 39 [patent_no_of_words] => 35705 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14705809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11750623 [patent_doc_number] => 09708626 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-18 [patent_title] => 'Regulatory nucleic acid elements' [patent_app_type] => utility [patent_app_number] => 14/699182 [patent_app_country] => US [patent_app_date] => 2015-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 29302 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14699182 [rel_patent_id] =>[rel_patent_doc_number] =>)